Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients
NCT03831633
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
426
Enrollment
INDUSTRY
Sponsor class
Conditions
Oncology
Interventions
DRUG:
Akynzeo
DRUG:
Standard of Care
Sponsor
VIFORFRANCE